← Leaderboards
Erick Strauss
Stellenbosch University
$675,183
Attributed
$675,183
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $141.2K · FY2018–22$200K$150K$100K$50K$0
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$675,183 · 1
By mechanism
R01$675,183 · 1
Top collaborators
No co-investigators on record.
Most similar at Stellenbosch University
Same institution · by research overlap
- Joshua James Reineke$544,089
- Samantha Leigh Sampson$1,007,841
- John T Belisle$22,161,703
- Marisa Klopper$318,264
- Elizabeth Maria Streicher$710,388
Others in their field
Other Emerging Leaders on “Aerobic”
- Susan M Landau · University Of California Berkeley$47,252,026
- Jessica Scott · Sloan-Kettering Inst Can Research$10,593,887
- Alexander Egbe · Mayo Clinic Rochester$7,415,297
- Andrei G. Vlassenko · Washington University$6,750,146
- Pierce Boyne · University Of Cincinnati$5,412,610
- Mark Andrew Sarzynski · Beth Israel Deaconess Medical Center$4,936,886
Research focus
AerobicAnabolismAnaerobic BacteriaAnalogAnti-Bacterial AgentsAntibioticsAntitubercular AgentsBackBacteriaBactericideBaseBindingBiochemicalBypassCell EnvelopeCellsCellular AssayChronic InfectionCoenzyme ACofactorCo-InfectionCommunicable DiseasesCommunitiesAdherence
Grant awards (5)
Inhibitors of CoA biosynthesis as novel antitubercular and antistaphylococcal agents$127,215
R01 · FY2022 · AI · contact PI
Inhibitors of CoA biosynthesis as novel antitubercular and antistaphylococcal agents$130,987
R01 · FY2021 · AI · contact PI
Inhibitors of CoA biosynthesis as novel antitubercular and antistaphylococcal agents$135,431
R01 · FY2020 · AI · contact PI
Inhibitors of CoA biosynthesis as novel antitubercular and antistaphylococcal agents$141,173
R01 · FY2019 · AI · contact PI
Inhibitors of CoA biosynthesis as novel antitubercular and antistaphylococcal agents$140,377
R01 · FY2018 · AI · contact PI